USTEKINUMAB-TTWE
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for USTEKINUMAB-TTWE, covering 2024-06-28 to 2025-11-18. Get the full timeline:
Most recent: FDA Approved: USTEKINUMAB-TTWE — Supplemental Application (Quallent Pharmaceuticals Health LLC)